Agenda

*topics subject to change prior to date of event

7:00 am REGISTRATION, EXHIBITS AND BREAKFAST
7:15 am LABCORP SPONSORED BREAKFAST
Dr. Henry Dong, M.D.
8:00 am WELCOME AND INTRODUCTION
Elias Anaissie, M.D. and James H. Essell, M.D.
8:10 am HEMATOLOGICAL DISORDERS OF PREGNANCY
Kenneth Bauer, M.D.
8:40 am ORAL ANTICOAGULATION FOR PRIMARY AND SECONDARY PREVENTION OF CANCER-ASSOCIATED THROMBOSIS
Alok Khorana, M.D.
9:10 am APPROACH TO THE ADULT WITH THROMBOCYTOPENIA
Marshall Mazepa, M.D.
9:40 am PANEL DISCUSSION
9:50 am BREAK
10:00 am HOW TO IMPROVE THE OUTCOME IN HIGH-RISK AML?
John De Persio, M.D., Ph.D.
10:45 am OPTIMIZING THERAPY FOR ADULTS WITH ACUTE LYMPHOBLASTIC LEUKEMIA
Elias Jabbour, M.D.
11:15 am INDIVIDUALIZING THERAPY FOR PATIENTS WITH RESISTANT / REFRACTORY MYELOMA
Robert Z. Orlowski, M.D., Ph.D.
11:45 am PANEL DISCUSSION
12:00 pm DISMISS FOR LUNCH
12:15 pm PHARMACYCLICS SPONSORED LUNCH
Hillard Lazarus, M.D.. FACP
1:00 pm TARGETING THE B CELL RECEPTOR PATHWAY IN CLL AND LOW-GRADE NHL
Clive S. Zent, M.D.
1:30 pm THE ARTFUL MANAGEMENT OF PATIENTS WITH CML: AN UPDATE
Charles Schiffer, M.D.
2:00 pm INDIVIDUALIZING THERAPY FOR HODGKIN LYMPHOMA
David J. Straus, M.D.
2:30 pm PANEL DISCUSSION
2:40 pm BREAK
2:50 pm MANAGING MDS IN THE RELAPSE SETTING
Charles Schiffer, M.D.
3:20 pm AGGRESSIVE NHL: TREATMENT OF NEWLY DIAGNOSED AND RELAPSED DISEASE
Koen van Besien, M.D., Ph.D.
3:50 pm IMMUNOTHERAPY FOR HEMATOLOGIC MALIGNANCIES: CAR-T AND BEYOND
Nina Shah, M.D.
4:20 pm PANEL DISCUSSION
4:30 pm CLOSING REMARKS